Drug Eluting Stent Market - Forecasts from 2025 to 2030

The Drug eluting stent market is projected to grow at a CAGR of 8.20% over the forecast period, increasing from US$11.499 billion in 2025 to US$17.049 billion by 2030.
A drug-eluting stent is a metallic, semi-rigid tubular device that has a drug attached to it, allowing for a slow release of medication to prevent the recurrence of stenosis or arterial obstruction. Recent innovations in stent designs and delivery technologies are expected to significantly reduce the restenosis rate, even in complex lesions, thereby decreasing the incidence of both early and late thrombosis. The growing geriatric population worldwide is a major driver for the drug-eluting stent market, as the likelihood of developing vascular diseases increases with age, leading to greater demand for effective treatment options like drug-eluting stents. Additionally, sedentary lifestyles and poor dietary habits are contributing to a rise in cases of atherosclerosis, characterized by plaque buildup in the arteries.
Drivers of the Drug-Eluting Stent Market

Technological Advancements: The transition from standard angioplasty to drug-eluting stents (DES) represents a significant advancement in treatment options. By integrating medication therapy directly onto the stent, this minimally invasive approach offers numerous benefits, including reduced stress on blood vessels, faster recovery times, and lower complication risks. For example, the Orsiro Mission represents a technological breakthrough that delivers drugs directly into target arteries, thereby improving patient outcomes. The successful implementation of such innovative solutions is likely to increase market activity as healthcare professionals seek more effective and less invasive treatments for arterial disorders.

Geographical Outlook

North America Expected to Lead: North America is projected to hold a substantial share of the drug-eluting stent market during the forecast period. This growth can be attributed to favorable reimbursement policies and a rising incidence of artery-related diseases in the region. Furthermore, advancements in drug-eluting stent technology and a robust healthcare infrastructure have contributed to market expansion. According to the Journal of the American College of Cardiology published in February 2023, the incidence rate of atherosclerotic cardiovascular disease in the United States was 2.60 per 1,000 person-years among individuals with high 10-year predicted risk. This statistic underscores the growing need for effective treatment options like drug-eluting stents.
As the aging population is more susceptible to cardiovascular diseases such as coronary artery disease (CAD), there is an increasing demand for drug-eluting stents among older patients. Studies indicate that CAD affects approximately 50% of older women and 70%-80% of older men. Additionally, Canada's elderly population is projected to grow significantly over the next two decades, further driving demand for these medical devices.In summary, factors such as rising technological innovations and an increasing prevalence of cardiovascular diseases are expected to propel growth in the drug-eluting stent market, particularly in North America.

Reasons for buying this report:

Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, other sub- segments.

Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.

Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape up future market developments.

Actionable Recommendations: Utilize the insights to exercise strategic decision to uncover new business streams and revenues in a dynamic environment.

Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

Historical data & forecasts from 2022 to 2030

Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, Customer Behaviour, and Trend Analysis

Competitive Positioning, Strategies, and Market Share Analysis

Revenue Growth and Forecast Assessment of segments and regions including countries

Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)
The Drug eluting stent market is segmented and analyzed as follows:

By Coating Type

Polymer-Based Coating
Polymer-Free Coating.

By Application

Coronary Artery Disease (CAD)
Peripheral Artery Disease (PAD)

By End-User

Hospitals
Ambulatory Surgical Centers
Others

By Geography

North America
USA
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
Germany
UK
France
Spain
Others
Middle East and Africa
UAE
Israel
Others
Asia Pacific
China
Japan
South Korea
India
Indonesia
Taiwan
Thailand
Others